Catalog record · Data & Analytics
Stage as of source date not established · historical report, not live reconfirmation.
Moderna clinical-development analysis assistant pilot
Vendor workflow source. A reviewed supplier account names the customer and workflow. Supplier attribution and deployment claims are not independent outcome validation.
Last researched Oct 26, 2026. Source access and reported stage are recorded below; deployment evidence does not establish ROI.
What the research supports
The GPT pilot assists a clinical study team with data analysis, visualizations and referenced rationale for dose discussions.
- Reported stage
- Pilot
- Technology
- GenAI/LLM
- Business function
- Middle Office
- Impact (legacy label)
- Not labeled
- Catalog date · unconfirmed
- Not reported
- Imported
- Oct 29, 2026
- Last researched
- Oct 26, 2026
Measures & evidence
No quantified measure recorded. This is a gap in the evidence, not a finding of no value.
Documented vendor relationships
No vendor relationship has been linked to this specific workflow in the curated overlay. This does not mean it was built without vendors.
See the company’s documented relationshipsDeployment evidence & limits
OpenAI explicitly calls Dose ID a pilot still being developed and validated. Status date not established.
Stage is as reported in the cited evidence. Current operating status has not been independently reconfirmed; the research date is an editorial review date.
Vendor customer story; no controlled performance evidence, production approval or clinical efficacy claim. Validate generated code, statistics and references; medical dose-selection performance is not evidence of credit or portfolio decision quality.
Potential FS application · inferred
Inferred: Risk-model development teams: create reproducible scenario charts and analytical explanations for human model-review committees.
Conversational analysis makes large datasets interrogable while preserving a qualified team's decision responsibility.
Original industry: Pharmaceuticals and biotechnology. Transfer limits: Validate generated code, statistics and references; medical dose-selection performance is not evidence of credit or portfolio decision quality.
Recorded dependencies
- Traceable source data and approved document/control schemas
- Qualified human review and local testing of accuracy, omissions and full workflow effort
Source register
- Modernaopenai.com · opens in a new tab
OpenAI · vendor-case · full-text · Publication date not recorded
Research lanes: health_life_sciences · Batch global-discovery-2026-10-26. Coverage and remaining gaps